Os Therapies Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$1.90

-0.34 (-15.18%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,614.2% upside

Low Target $26.16

Average Target $32.57

High Target $50.99

Current Price $1.90

Current
$1.90

Target
$32.57

$26.16 $32.57 avg $50.99

Scenario Analysis

Bear Case

$26.16

1,276.8%

Low target

Base Case

$32.57

+1,614.2%

Avg target

Bull Case

$50.99

+2,583.7%

High target

Risk/Reward

2.0x

Favorable

Price in Context

52-Week High

$2.57

-26.1% from high

52-Week Low

$1.15

+65.2% from low

Target vs 52W High

$32.57

+1,167.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%